US FDA flags shortage of neurosurgical pads and sponges, expects disruption through 2026
Reuters reports that the U.S. Food and Drug Administration has added certain neurosurgical patties, sponges and strips to its medical device shortages list following supply disruptions tied to a product recall. The article includes insights from Karen Niven, senior director of clinical value analysis at Premier, who noted that Premier has advised member hospitals to focus on conservation strategies given the products’ importance in brain and spine surgeries.
